Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trametinib for multiple non-ossifying fibromas due to KRAS mosaic mutations: two case reports.

Communications medicine·2026
Same author

Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases.

EBioMedicine·2026
Same author

Clinical predictors of remission in systemic juvenile idiopathic arthritis/Still's disease: insight from real-life data and the potential relevance of the 'window of opportunity'.

Clinical and experimental rheumatology·2025
Same author

Indications, efficacy and safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohort.

Rheumatology (Oxford, England)·2025
Same author

Evaluation of the benefits of adapted physical activity in children and adolescents with osteogenesis imperfecta: the MOVE-OI trial.

Orphanet journal of rare diseases·2025
Same author

French evaluation of innovative health technologies: Early access and fundings.

Presse medicale (Paris, France : 1983)·2025
Same journal

Identifying outcome measures for clinical trials in juvenile idiopathic arthritis associated uveitis for the MIWGUC proposal: a scoping review to create domains from existing outcome measures.

Pediatric rheumatology online journal·2026
Same journal

Vaccination coverage and serological follow-up in children with rheumatologic diseases: a retrospective single-centre study.

Pediatric rheumatology online journal·2026
Same journal

Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide study.

Pediatric rheumatology online journal·2026
Same journal

The use of JAK inhibitors and tocilizumab in the management of TRAPS: a sibling case study.

Pediatric rheumatology online journal·2026
Same journal

Update on clinimetric assessments in juvenile dermatomyositis: conceptual foundations, current tools, and future directions : (Narrative review describing the development, validation, and application of clinimetric outcome measures in juvenile dermatomyositis).

Pediatric rheumatology online journal·2026
Same journal

Clinical correlates and predictors of thrombocytopenia in childhood-onset systemic lupus erythematosus: a retrospective cohort study.

Pediatric rheumatology online journal·2026
See all related articles

Related Experiment Videos

Takayasu arteritis in children.

Safia Al Abrawi1, Marine Fouillet-Desjonqueres, Louis David

  • 1Département de pédiatrie, Hôpital Edouard-Herriot and Université Claude-Bernard Lyon1, Lyon, France. r.cimaz@meyer.it.

Pediatric Rheumatology Online Journal
|September 30, 2008
PubMed
Summary
This summary is machine-generated.

Takayasu arteritis (TA), a large vessel vasculitis, can affect children, presenting with hypertension and ischemic pain. Early diagnosis and treatment with immunosuppressants and antihypertensives are crucial for managing this rare pediatric condition.

Related Experiment Videos

Area of Science:

  • Pediatric Rheumatology
  • Vascular Inflammation
  • Autoimmune Diseases

Background:

  • Takayasu arteritis (TA) is a rare large vessel vasculitis predominantly affecting young women.
  • While typically diagnosed in the second and third decades of life, TA can manifest in childhood, even in patients as young as 24 months.
  • Understanding pediatric TA is critical due to its potential for severe vascular complications.

Purpose of the Study:

  • To describe four pediatric cases of Takayasu arteritis.
  • To summarize key findings from published studies on childhood TA.
  • To highlight clinical presentation, diagnostic features, and treatment outcomes in pediatric TA.

Main Methods:

  • Retrospective case series of four children diagnosed with TA.
  • Review of relevant published literature on pediatric Takayasu arteritis.
  • Analysis of clinical data including age, ethnicity, symptoms, imaging, inflammatory markers, and treatment responses.

Main Results:

  • The mean age of presentation in the four cases was 11 years (range 8-15).
  • Common presentations included arterial hypertension and systemic symptoms, with ischemic pain in limbs, chest, and abdomen.
  • Angiography revealed frequent involvement of the left subclavian and common carotid arteries; two patients had renal artery stenosis.
  • One patient had an associated Wiskott-Aldrich syndrome, an immune deficiency.

Conclusions:

  • Takayasu arteritis in children presents with diverse symptoms, often including hypertension and ischemic manifestations.
  • Prompt diagnosis supported by imaging and inflammatory markers is essential for effective management.
  • Treatment involves immunosuppressants and antihypertensives, with potential need for surgery, and long-term monitoring is required.